EA200900923A1 - Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний - Google Patents

Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний

Info

Publication number
EA200900923A1
EA200900923A1 EA200900923A EA200900923A EA200900923A1 EA 200900923 A1 EA200900923 A1 EA 200900923A1 EA 200900923 A EA200900923 A EA 200900923A EA 200900923 A EA200900923 A EA 200900923A EA 200900923 A1 EA200900923 A1 EA 200900923A1
Authority
EA
Eurasian Patent Office
Prior art keywords
treatment
neuroprotective
medicines
connections
obtaining
Prior art date
Application number
EA200900923A
Other languages
English (en)
Inventor
Ален Ле-Ридан
Катрин Арпей
Original Assignee
Ле Лаборатуар Сервье
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ле Лаборатуар Сервье filed Critical Ле Лаборатуар Сервье
Publication of EA200900923A1 publication Critical patent/EA200900923A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Abstract

Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративного заболевания и/или предотвращения возникновения расстройств, являющихся результатом этих заболеваний.
EA200900923A 2007-01-05 2008-01-04 Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний EA200900923A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0700048A FR2911143A1 (fr) 2007-01-05 2007-01-05 Utilisation de composes neuroprotecteurs pour l'obtention de medicaments destines au traitement de maladies neurodegeneratives.
PCT/FR2008/000014 WO2008099083A2 (fr) 2007-01-05 2008-01-04 Utilisation de composes neuroprotecteurs pour l'obtention de médicaments destines au traitement de maladies neurodegeneratives

Publications (1)

Publication Number Publication Date
EA200900923A1 true EA200900923A1 (ru) 2009-12-30

Family

ID=38309971

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900923A EA200900923A1 (ru) 2007-01-05 2008-01-04 Применение нейропротективных соединений в получении лекарственных средств, предназначенных для лечения нейродегенеративных заболеваний

Country Status (14)

Country Link
US (1) US20090298813A1 (ru)
EP (1) EP2101768A2 (ru)
JP (1) JP2010514827A (ru)
KR (1) KR20090104853A (ru)
CN (1) CN101578100A (ru)
AR (1) AR064749A1 (ru)
AU (1) AU2008214550A1 (ru)
BR (1) BRPI0806275A2 (ru)
CA (1) CA2674100A1 (ru)
EA (1) EA200900923A1 (ru)
FR (1) FR2911143A1 (ru)
MA (1) MA31032B1 (ru)
MX (1) MX2009007198A (ru)
WO (1) WO2008099083A2 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926077A1 (fr) * 2008-01-04 2009-07-10 Servier Lab Nouveaux derives d'1h-indol-1-yl uree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
JP6154282B2 (ja) * 2013-10-03 2017-06-28 株式会社ファンケル 神経幹細胞又は神経前駆細胞の増殖促進剤
CN111018802B (zh) * 2019-12-03 2021-07-06 湖北大学 具有抗帕金森氏症的化合物、制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA786426B (en) * 1977-11-25 1979-10-31 Scras New indulo(2,3-a)quinolizidines,preparation and therapeutic use
FR2713644B1 (fr) * 1993-12-14 1996-02-09 Adir Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
EP1470818B1 (en) * 2003-04-25 2006-07-26 Neuro3D Use of piperazine phenothiazine derivatives in the manufacture of a medicament with neuroprotector and/or neurotrophic effects on cns and/or pns
CN1566099A (zh) * 2003-06-13 2005-01-19 中国科学院上海药物研究所 异喹啉－1,3,4－三酮类化合物、制备方法及其用途

Also Published As

Publication number Publication date
US20090298813A1 (en) 2009-12-03
BRPI0806275A2 (pt) 2011-09-06
JP2010514827A (ja) 2010-05-06
MX2009007198A (es) 2009-08-12
WO2008099083A2 (fr) 2008-08-21
EP2101768A2 (fr) 2009-09-23
MA31032B1 (fr) 2009-12-01
WO2008099083A3 (fr) 2008-12-11
AU2008214550A1 (en) 2008-08-21
CA2674100A1 (fr) 2008-08-21
FR2911143A1 (fr) 2008-07-11
CN101578100A (zh) 2009-11-11
KR20090104853A (ko) 2009-10-06
AR064749A1 (es) 2009-04-22

Similar Documents

Publication Publication Date Title
CY1112320T1 (el) Τιτλοδοτηση της ταπενταδολης
UA94734C2 (ru) ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ
NO20081527L (no) Anvendelse av flibanserin for behandling av pre-menopausal seksuell lyst forstyrrelser
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
ATE538652T1 (de) Synergistische pharmazeutische kombination für die behandlung von krebs
LTC1781298I2 (lt) Farmacinės kompozicijos, turinčios benzoksazino, skirtos respiracinių ligų gydymui
NO20084531L (no) Bruk av flibanserin for behandling av post-menopause seksuell lyst lidelser
MX2013006591A (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
EA201401028A1 (ru) Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
MX2010006204A (es) Derivados de oxindol 5,6-disubstituidos y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
BR112014032917A2 (pt) compostos e usos terapêuticos dos mesmos
DK1940409T3 (da) Nye lægemiddelkombinationer til behandling af åndedrætssygdomme
EA201400969A1 (ru) Новые терапевтические подходы для лечения болезни паркинсона
ATE543804T1 (de) Neue verbindungen
GT200600109A (es) Derivados de acido pirimidincarboxilico y su uso
BR112012002265A2 (pt) composições farmacêuticas para o tratamento de câncer e outras doenças ou distúrbios
HN2009003424A (es) (oxazolidinon-5-il-metil) -2-tiofen-carboxamidas sustituida y su uso en el campo de la coagulacion sanguinea
PT2364711T (pt) Utilização de extratos de pele de coelho inflamada pelo vírus vaccinia para o fabrico de um medicamento para o tratamento da doença cerebrovascular aguda
DK1856070T3 (da) Nye lægemidler til behandling af luftvejssygdomme
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол
FR2918282B1 (fr) Medicament pour le traitement de la maladie de parkinson
DK1786442T3 (da) Behandling af neurodegenerative sygdomme under anvendelse af DEGS-inhibitorer